Cargando…

Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer

A complete proteomics study characterizing active androgen receptor (AR) complexes in prostate cancer (PCa) cells identified a diversity of protein interactors with tumorigenic annotations, including known RNA splicing factors. Thus, we chose to further investigate the functional role of AR-mediated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seltzer, Sean, Giannopoulos, Paresa N, Bismar, Tarek A, Trifiro, Mark, Paliouras, Miltiadis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226513/ https://www.ncbi.nlm.nih.gov/pubmed/36259569 http://dx.doi.org/10.4103/aja202263

Ejemplares similares

Proteomic-Coupled-Network Analysis of T877A-Androgen Receptor Interactomes Can Predict Clinical Prostate Cancer Outcomes between White (Non-Hispanic) and African-American Groups
por: Zaman, Naif, et al.
Publicado: (2014)

Genome-wide analysis of androgen receptor binding and transcriptomic analysis in mesenchymal subsets during prostate development
por: Nash, Claire, et al.
Publicado: (2019)

Mechanisms Mediating Spinal and Bulbar Muscular Atrophy: Investigations into Polyglutamine-Expanded Androgen Receptor Function and Dysfunction
por: Beitel, Lenore K., et al.
Publicado: (2013)

Functionalized Carbon Nanoparticles as Theranostic Agents and Their Future Clinical Utility in Oncology
por: Lee, Seung S., et al.
Publicado: (2023)

The Association between Cyclin Dependent Kinase 2 Associated Protein 1 (CDK2AP1) and Molecular Subtypes of Lethal Prostate Cancer
por: Gamallat, Yaser, et al.
Publicado: (2022)

ING3 promotes prostate cancer growth by activating the androgen receptor
por: Nabbi, Arash, et al.
Publicado: (2017)

Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer
por: Munkley, Jennifer, et al.
Publicado: (2019)

ARPC1B Is Associated with Lethal Prostate Cancer and Its Inhibition Decreases Cell Invasion and Migration In Vitro
por: Gamallat, Yaser, et al.
Publicado: (2022)

Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing
por: Shah, Kalpit, et al.
Publicado: (2020)

Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma
por: Leivonen, S-K, et al.
Publicado: (2017)

Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate Cancer
por: Gamallat, Yaser, et al.
Publicado: (2023)

Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells
por: Dotan, Idit, et al.
Publicado: (2016)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Jillson, Lauren K., et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease
por: Walker, Simon R., et al.
Publicado: (2021)

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
por: Asim, Mohammad, et al.
Publicado: (2017)

Alternative Splicing Programs in Prostate Cancer
por: Sette, Claudio
Publicado: (2013)

A Unique, Consistent Identifier for Alternatively Spliced Transcript Variants
por: Riva, Alberto, et al.
Publicado: (2009)

Schizophyllum commune has an extensive and functional alternative splicing repertoire
por: Gehrmann, Thies, et al.
Publicado: (2016)

Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis
por: Al Bashir, Samir, et al.
Publicado: (2014)

Editorial: The Application of Proteogenomics to Urine Analysis for the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study
por: Gamallat, Yaser, et al.
Publicado: (2023)

Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation
por: Duan, Lingling, et al.
Publicado: (2019)

Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells
por: Dotan, Idit, et al.
Publicado: (2016)

High Serine-arginine Protein Kinase 1 Expression with PTEN Loss Defines Aggressive Phenotype of Prostate Cancer Associated with Lethal Outcome and Decreased Overall Survival
por: Abou-Ouf, Hatem, et al.
Publicado: (2020)

Androgen receptor splice variants and prostate cancer: From bench to bedside
por: Wadosky, Kristine M., et al.
Publicado: (2017)

Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate Cancer
por: Bhoir, Siddhant, et al.
Publicado: (2023)

Drosophila Sister-of-Sex-lethal reinforces a male-specific gene expression pattern by controlling Sex-lethal alternative splicing
por: Moschall, Rebecca, et al.
Publicado: (2019)

Alternative splicing of CCN mRNAs …. it has been upon us
por: Perbal, Bernard
Publicado: (2009)

SOX9 has distinct regulatory roles in alternative splicing and transcription
por: Girardot, Michael, et al.
Publicado: (2018)

Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: A Literature Review
por: Dhavale, Meera, et al.
Publicado: (2021)

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
por: Sekine, Yoshitaka, et al.
Publicado: (2021)

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
por: Messner, Elisabeth A., et al.
Publicado: (2020)

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer
por: Tolkach, Yuri, et al.
Publicado: (2022)

Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer
por: Shin, Won Sik, et al.
Publicado: (2023)

Loss of Wave1 gene defines a subtype of lethal prostate cancer
por: Sowalsky, Adam G., et al.
Publicado: (2015)

PPS, a Large Multidomain Protein, Functions with Sex-Lethal to Regulate Alternative Splicing in Drosophila
por: Johnson, Matthew L., et al.
Publicado: (2010)

Species-specific alternative splicing leads to unique expression of sno-lncRNAs
por: Zhang, Xiao-Ou, et al.
Publicado: (2014)

FOXA1 regulates alternative splicing in prostate cancer
por: Del Giudice, Marco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_frpie3lvf76b1qo9mh5a7c2lnp